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 Patients with posttraumatic stress disorder (PTSD) often show impaired ability to 
discriminate between “danger” and “safety” cues. Women are more than twice as likely 
to be diagnosed with PTSD as compared to men; however, translational research has 
largely relied on the use of male subjects despite evidence of sex differences in fear-
motivated behaviors. Serotonergic activity, originating in the dorsal raphe nucleus (DRN) 
of the central nervous system (CNS), has been found to modulate fear discrimination in 
males and may contribute to sex differences observed in a Pavlovian fear discrimination 
paradigm. In this study, male and intact female Sprague-Dawley rats were exposed to 
fear conditioning with (CS+/CS-) or without (CS+) a safe conditioned stimulus, then 
subsequently sacrificed for immunohistochemical analysis of serotonergic activity via 
quantification of tryptophan hydroxylase (TPH) and Fos in the DRN. Females exhibited 
more rapid and robust discrimination between the CS+ danger cue and CS- safety cue as 
compared to males. Regardless of condition, females had more double-labeled TPH+Fos 
cells compared to males, but males had larger variation in TPH+Fos expression compared 
to females. A parabolic function for TPH+Fos counts predicted fear discrimination in 
males, but not females, reinforcing the view that serotonin is a modulator of safety-
related behavior in males. 
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1.0  INTRODUCTION 
Posttraumatic stress disorder (PTSD) is a mental health disorder that an individual 
may develop after witnessing or experiencing an extremely stressful or traumatic event 
such as combat, sexual assault, or vehicular accidents. One distinguishing characteristic 
of PTSD is the inability to distinguish between danger and safety (Jovanovic et al., 
2012)—people with PTSD often experience the “fight-or-flight” stress response even 
when in a safe environment as a result of a “trigger” in the surroundings that reminds him 
or her of the traumatic event. Research aimed at identifying the biological mechanisms by 
which stressors reduce the efficacy of safety signals may lead to new targets for therapy 
of PTSD. 
 Associative safety learning, based on Pavlovian conditioning (Pavlov, 1927), is 
often used as an experimental model for studying the impaired fear behaviors endemic to 
PTSD and the neural mechanisms that underlie them. Fear discrimination is one instance, 
in which a subject is presented with an emotionally neutral conditioned stimulus (CS) 
(e.g., a flashing LED light) paired with a salient unconditioned stimulus (US) (e.g., a 
footshock) such that the subject learns to associate the “danger” cue with impending 
aversive stimulation—this becomes the CS+. A “safety” cue (e.g., a unique tone) that is 
not paired with an aversive US, and so does not predict aversive stimulation, becomes the 
CS-. Neurotypical individuals readily distinguish between the CS+ and CS-, but those 
with PTSD are unable to exhibit the same level of fear discrimination. Experimental 
animals are subjected to this fear discrimination paradigm to further study PTSD.  
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The basolateral amygdala’s (BLA) evolutionary function and the modulatory 
effects of serotonin (5-hydroxytryptamine; 5-HT) have been identified as key 
components in the regulation of fear behaviors (Lowry et al., 2005; Homberg, 2012; 
Bocchio et al., 2016), with the continued use but controversial efficacy of selective 
serotonin reuptake inhibitors (SSRIs) to treat anxiety and depressive-like symptoms 
(Mӧller, 2009) indicative of the fact that we have yet to have a firm understanding of the 
neurocircuitry that underlies such behaviors.  
Additionally, results from translational research have come from the almost 
exclusive use of male subjects, even though women are more than twice as likely as men 
to be diagnosed with PTSD due to various physiological and psychosocial factors 
(Breslau et al., 1999b; Kessler et al., 2012) and other studies have replicated the 
phenomenon that females exhibit more robust fear discrimination as compared to males 
(Day et al., 2016; Foilb et al., 2017).  
In this study, we examined potential sex differences in the dorsal raphe nucleus 
(DRN), the origin of 5-HT in the central nervous system (CNS), that could explain 
observed sex differences in a fear discrimination paradigm.  
1.1 SEROTONIN (5-HT) 
5-HT is a monoamine neurotransmitter synthesized from tryptophan by 
tryptophan hydroxylase 2 (TPH), a CNS-specific TPH isoform (Walther and Bader, 
2003). During synaptic transmission, 5-HT is released from the presynaptic neuron and 
binds to its associated receptors on the postsynaptic membrane. 5-HT receptor subtypes 
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have been classified based on their coding sequences, protein morphologies, regional 
distributions, pharmacological profiles, and modulatory effects on brain functions that 
give rise to animal behaviors (for reviews see Boess and Martin, 1993; Barnes and Sharp, 
1999). It is argued that the specificity of signaling between 5-HT and its receptors mainly 
depends on general mechanisms of synaptic transmission—namely, the rate of 5-HT 
synthesis and reuptake, extracellular concentration of the neurotransmitter, diversity and 
distribution of its receptors, and specific methods of transmission throughout the CNS. 
5-HT can be transmitted by “wired transmission,” characterized by transmission 
at synapses, and “volume transmission,” characterized by transmission through the 
extracellular space that includes non-synaptic receptors (Agnati et al., 1995; 2010). 5-HT 
released from junctional (i.e., synaptic) and non-junctional sites has been shown to 
escape the synaptic cleft and diffuse into the extracellular space in a paracrine fashion 
until reuptaken into the presynaptic neuron by ATP-dependent 5-HT transporters. These 
two modes of transmission may represent complementary modes of communication, with 
the former involved in short-term signaling and the latter involved in long-term 
modulation of cellular networks (Fuxe et al., 2007).  
Serotonergic neurons originating in the pons of the brainstem—an area containing 
the DRN—project to the forebrain. A rostral and ventral pathway emerge from this group 
of neurons, with a longitudinal rostral projection running through the medial forebrain to 
innervate the BLA (Charnay and Léger, 2010), which contains a dense meshwork of 
serotonergic axons and 5-HT transporters (Smith and Porrino, 2008). Neurons from the 
DRN that project to the BLA originate from the dorsomedial part of the DRN (Abrams et 
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al., 2004), are neurochemically distinct (Commons et al., 2003), and receive unique 
afferent input (Peyron et al., 1997).  
1.2 NEUROBIOLOGY OF FEAR CONDITIONING IN THE BLA 
The BLA receives primarily cortical, hippocampal, and sensory inputs, with most 
of its outputs projecting to the brainstem and brainstem-driving intermediate structures 
(Swanson and Petrovich, 1998). The ability for the BLA to assign valence to sensory 
stimuli—particularly those associated with emotionally charged events—involves 
crosstalk with other brain structures and modulation by neurotransmitters such as 5-HT, 
making it an area of interest in safety learning (LeDoux, 2007).  
Immunohistochemical and electrophysiological techniques have distinguished 
between two main types of neurons within the BLA. Pyramidal neurons in the BLA, 
which comprise approximately 70% of the structure’s cell population, are 
immunoreactive to glutamate, suggesting that they are excitatory in nature (Smith and 
Paré, 1994). Conversely, local interneurons in the BLA are immunoreactive to γ-
aminobutyric acid (GABA) (McDonald and Augustine, 1993), suggesting that they are 
inhibitory in nature.  
Plastic events within the BLA are thought to be necessary in enabling the CS to 
become associated with the nociceptive and emotional valence of the US and trigger the 
behavioral, autonomic, and endocrine characteristics of the stress response. Through 
exposure to stressful stimuli, the BLA can promote the establishment of long-term fear 
memory in a process known as consolidation. Transmission of the sensory information of 
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the CS to the BLA leads to the release of glutamate from sensory inputs onto AMPA 
receptors. If a strong enough US is presented to the neuron at the same time as the CS, an 
increase in excitatory input causes the removal of the Mg2+ block from nearby NMDA 
receptors and allows extracellular Ca2+ to enter the postsynaptic membrane through the 
NMDA receptor and other Ca2+ ion channels. Increased concentrations of intracellular 
Ca2+ result in phosphorylation cascades which have further downstream effects within the 
cell via CaMKII activity for an overall enhancement of synaptic transmission (Manilow 
et al., 1989, Lisman et al., 2002). This process, known as long-term potentiation, induces 
the synthesis of proteins that play a role in synaptic plasticity and memory consolidation 
(Stanton and Sarvey, 1984), such as new AMPA receptors which are inserted into the 
postsynaptic membrane to facilitate subsequent Ca2+ influxes (Shi et al., 1999, Sanderson 
et al., 2016) in a positive feedback loop. 
McKernan and Shinnick-Gallagher (1997) found that rats that had undergone fear 
conditioning showed enhanced amplitude of synaptic currents in amygdaloid neurons in 
vitro, and Maren (1999) and other groups later found that administration of NMDA 
receptor antagonists into the BLA effectively prevented fear conditioning. Activity in 
local inhibitory circuits has also been found to mediate fear behaviors, as different 
treatments that increased GABA transmission were found to impair the acquisition 
(Sanger and Joly, 1985) and expression (Harris and Westbrook, 1999; 2001) of 
conditioned fear.  
The BLA has also been shown to exhibit synaptic plasticity after exposure to 
safety cues. Ostroff et al. (2010) identified morphological changes in the dendritic spines 
of excitatory amygdaloid neurons, where fear conditioning resulted in larger spines but 
 6 
presentation of unpaired cues resulted in smaller spines. On a macroscopic scale, Sangha 
et al. (2013) identified unique populations of neurons whose firing rates encoded the 
danger cue, the safety cue, or both. As the spatiotemporal properties of long-term 
potentiation have been shown during CS-US association in fear conditioning (Rogan et 
al., 1997; Shin et al., 2006), this mechanism can also serve as a working model for neural 
activity during fear discrimination and fear memory consolidation in the BLA.  
1.3 SEROTONERGIC MODULATION OF FEAR BEHAVIORS 
Using retrograde tracers injected into the anterior part of the BLA, Abrams et al. 
(2005) identified a “shell” subregion of the mid-DRN as the potential origin of 
serotonergic modulation of fear behaviors, providing further anatomical support to the 
existing hypothesis that 5-HT plays a modulatory role in a range of emotionally salient 
behavioral responses. Other studies in which direct application of 5-HT or related drugs 
into the BLA influenced the stress response provide pharmacological support for 
serotonergic modulation of fear behaviors.  
The DRN-BLA system is affected by exogenous stimuli and drugs in a time- and 
dose-dependent manner. Electrical stimulation of the DRN inhibited neural activity in the 
BLA in vivo (Wang and Aghajanian, 1977), an effect replicated with late acute 
administration of 5-HT into the BLA that increased depolarization in interneurons and 
hyperpolarization in pyramidal neurons (Rainnie, 1999). Axons that innervate pyramidal 
neurons and interneurons in the BLA were immunoreactive to 5-HT, and serial sectioning 
transmission electron microscopy identified clusters of synaptic vesicles containing the 
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neurotransmitter (Muller et al., 2007). Therefore, if an increase in 5-HT were to inhibit 
the BLA, then synaptic plasticity would be impaired during learning, which would in turn 
impair short-term fear discrimination long-term fear memory consolidation. 
Exposure to stress, which produces long-lasting behavioral changes in 
experimental animals, has also been shown to involve the DRN (Maier and Watkins, 
2005) and serotonergic modulation in the BLA (Kawahara et al., 1993; Amat et al., 1998; 
Zanoveli et al., 2009). Other pharmacological manipulations revealed that 5-HT levels in 
the BLA after inescapable stress were mediated by 5-HT2C receptors (Campbell and 
Merchant, 2003; Christianson et al., 2010), which could improve performance in safety 
learning (Foilb and Christianson, 2015). Acute administration of SSRIs which transiently 
increased 5-HT levels in the BLA also increased anxiety-like behavior (Burghardt et al., 
2004; 2007), and Vicente and Zangrossi (2012) connected this effect of SSRIs with 
activity of 5-HT2C receptors in the BLA. These results suggest that transitory increases in 
5-HT in the BLA facilitate both the acquisition and expression of fear. 
Stress may cause an imbalance in the DRN-BLA system by downregulating local 
inhibitory 5-HT1A autoreceptor activity (Rozeske et al., 2011; Vicente and Zangrossi, 
2014; Li et al., 2012; Li et al., 2016) in the DRN to increase the firing rate of serotonergic 
neurons. The resulting increase of 5-HT that is released may lead to hyperexcitation of 
the DRN-BLA system and interfere with other properties of synaptic plasticity such as 
firing rate, gene expression, phosphorylation cascades, protein scaffolds, and lipid rafts to 
influence the establishment of long-term potentiation during fear discrimination (for 
review see Lesch and Waider, 2012). 
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A dual activity-increasing effect of serotonergic transmission of different neuron 
types in the BLA was indirectly suggested by Hale et al. (2010), who found that 
administration of anxiogenic drugs induced correlated increases in the expression of c-
Fos (hereafter referred to as “Fos”), a protein biomarker of neural activity expressed by 
the immediate early gene of the same name, in BLA interneurons. Fos was also strongly 
induced in BLA pyramidal neurons which have been shown to be activated by acute and 
repeated restraint stress (Reznikov et al., 2008). In conjunction with Abrams et al.’s 
(2005) similar observations in the DRN, these results provide further evidence of 
crosstalk within the DRN-BLA system. Hale et al. (2010) suggested that Fos expression 
in glutamatergic pyramidal neurons might be involved in the stress response itself, while 
the activation of GABAergic interneurons could contribute to its termination, 
corroborating the model of neuronal interaction in the BLA proposed by Rainnie (1999). 
 Considering the synthesis of 5-HT, sex differences in the serotonergic system may 
also be explained by TPH expression. Female TphII-/-  mice subjected to chronic mild 
stress exhibited increased anxiety-like behavior, reactivity to the US during conditioning, 
and levels of corticosterone metabolites as compared to males, suggesting that activation 
of the hypothalamic-pituitary-adrenal axis by 5-HT deficiency is more pronounced in 
females (Gutknecht et al., 2015). This hypothesis was supported by an observable 
decrease in Fos in the DRN in females after injections of corticotropin-releasing factor 
(Howerton et al., 2014). These results suggest that other hormones may also influence 
BLA activity and account for sex differences in the stress response.   
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1.4      AIM OF CURRENT STUDY 
While there is extensive work on the role of serotonergic modulation in the BLA 
during fear discrimination, most of these studies fail to consider the possibility of sex 
differences in this brain region. Additionally, no studies have examined serotonergic 
activity in the DRN as a neural correlate for observed sex differences in fear 
discrimination. Therefore, identifying sex differences in serotonergic activity at the likely 
origin of serotonergic modulation of fear behaviors would lead to a better understanding 
of the neurocircuitry of fear discrimination and the manifestation of PTSD in the human 
population.  
If pharmacological studies have shown that administration of a 5-HT2C receptor 
antagonist in fear-related structures such as the BLA could improve male subjects’ ability 
to discriminate (Foilb and Christianson, 2015), we hypothesized that females may already 
have low levels of 5-HT in the BLA that could explain their robust fear discrimination.  
In order to study sex differences in serotonergic activity, we first replicated sex 
differences in a fear discrimination paradigm. To allow for serotonergic modulation in 
the DRN-BLA system to function in its endogenous state, there was no experimental 
manipulation of the animals beyond that necessary to conduct behavioral testing. By 
performing immunohistochemistry on fixed DRN sections of all experimental animals, 
we could confidently identify serotonergic cells in the region that had been activated as a 
direct result of fear discrimination. By comparing average serotonergic activity between 
the sexes given the same conditioning treatment and correlating the number of activated 
serotonergic cells to the animal’s ability to discriminate, we could see if serotonergic 
activity in the DRN varied between the sexes and if it was an accurate predictor of fear 
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discrimination. Additionally, differences in morphology, TPH expression, and global 
activity in the DRN could also explain discrepancies in fear discrimination.      
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2.0  METHODS & MATERIALS 
2.1 SUBJECTS 
Intact male and normally cycling female adult Sprague-Dawley rats (n = 24/sex, 
Taconic Biosciences, Germantown, NY) were received at approximately 7 weeks old, 
kept in the same vivarium, and allowed 7-10 days to acclimate to the new environment 
before any experimental procedures. Animals were housed in isosexual pairs in plastic 
tub cages under a 12:12 light/dark cycle. Food and water were provided ad libitum. All 
experimental procedures were approved by the Boston College Institutional Animal Care 
and Use Committee and complied with the National Institutes of Health Guide for the 
Care and Use of Laboratory Animals. 
2.2 APPARATUS 
Fear discrimination conditioning occurred in 10 x 11 x 6 in. (L x W x H) black 
plastic chambers with wire mesh lids and a floor of stainless steel bars attached to a 
shocking grid (Model H10-11R-TC-SF, Coulbourn Instruments, Whitehall, PA) 
surrounded by a 15 x 12 x 27 in. (L x W x H) enclosure with ventilation and stochastic 
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noise (~55 dB) provided by a small fan. Each enclosure was equipped with two infrared 
LED lights (CMVision Model IR30) and one overhead camera (Model VX-5000, 
Microsoft, Redmond, VA) modified with an infrared passing filter to detect infrared light. 
A white LED light array (Model LPL620WTHD) and speakers affixed to the top of each 
enclosure provided conditioning stimuli.  
2.3 CONDITIONING 
The animals were assigned to the following treatments (n = 8/sex): fear 
discrimination conditioning consisting of 15 shock-paired CSs and 15 unpaired CSs 
(CS+/CS-), fear conditioning consisting of 15 shock-paired CSs (CS+ only), or a control 
group which was exposed to the fear discrimination stimuli without any shock (control). 
The conditioning stimuli were either auditory (10-ms white noise pips, 2 Hz, 75 dB) or 
visual (20-ms on/off flashing LED light, 264.0 Lux) cues which were counterbalanced 
across treatments. Freezing was video recorded and scored using ANY-Maze software 
(Version 4.99, Stoelting, Wood Dale, IL). All conditioning sessions were performed in 
the morning.         
Fear discrimination conditioning consisted of 15 presentations each of the CS+ 
and CS-. Trials began with a 5-second 1 kHz (75 dB) tone, followed by a 15-second cue 
presentation of either the CS+, which always co-terminated with a 500-ms, 1.2 mA 
scrambled footshock, or the CS-, which was never paired with a footshock. Animals were 
presented with the auditory and visual cues in quasi-random order such that no cue was 
presented more than twice in series, and a 70-second inter-trial interval separated each 
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cue presentation such that the session lasted 45 minutes. Fear conditioning trials began 
with the 5-second tone, followed by presentation of the CS+ for 15 seconds. Each CS+ 
presentation co-terminated with a footshock. An extended inter-trial interval of 
randomized length was presented after each cue presentation such that the full session 
lasted 45 minutes. The control treatment was exactly as the fear discrimination 
conditioning without any footshocks. 
2.4 ESTROUS CYCLE DETERMINATION AND ELISA TESTING 
Vaginal smears were obtained to determine estrous phase in the female rats. 
Estrous samples were collected at approximately the same time each day, 1 hour after the 
conditioning session. An eye dropper with 0.5 mL of saline solution was inserted 
approximately 5 mm into the vagina. Vaginal fluid was pipetted 3-4 times, placed on 
microscope slides, and coverslipped. Vaginal cytology was observed using light 
microscopy (American Optical Corporation, Model 1051, Buffalo, NY) at 10x 
magnification to determine estrous phase in accordance with guidelines described by 
Marcondes et al. (2002).          
After performing the vaginal smear, rats were anesthetized with tribromoethanol 
(i.p.), the thoracic cavity was opened, and approximately 2 mL of blood were collected 
via cardiac puncture. Blood was allowed to clot at room temperature and then centrifuged 
at 10,000 x g for 10 minutes at 4°C. Serum supernatant was preserved for later ELISA 
testing at -20°C (data not included). 
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2.5 IMMUNOHISTOCHEMISTRY 
After blood collection, rats were transcardially perfused with approximately 200 
mL of ice-cold PBS followed by 4% paraformaldehyde solution. Brains were extracted, 
post-fixed overnight and transferred to 30% sucrose solution. Brains were flash-frozen in 
2-methylbutane, and 40 µm slices (6.12 mm Bregma – -8.76 mm Bregma, Paxinos and 
Watson, 2006) were collected from a freezing cryostat (-20ºC, Leica Biosystems, 
Wetzlar, Germany). 1 out of 7 slices was directly mounted onto a gelatin subbed 
microscope slide for further cresyl violet staining and coverslipping with Permount 
(Thermo Fisher Scientific) for reference. 
Immunohistochemistry was performed at room temperature on DRN (B-6.84 mm 
– B-8.52 mm) slices. Sections were washed in 0.1 M PBS containing 0.1% Triton-X 100 
(PBST) and blocked in 5% normal donkey serum (Jackson ImmunoResearch) for 1 hour. 
Sections were then incubated in sheep anti-TPH primary antibody (1:1000; Sigma-
Aldrich; Product No. T8575-1VL; Lot No. SLBP0011V) overnight at 4ºC. Sections were 
washed in PBST, then incubated in donkey anti-sheep secondary antibody (1:200; 
Jackson ImmunoResearch; AlexaFluorⓇ 488 AffiniPure Donkey Anti-Sheep IgG (H+L); 
Product No. 713-545-147; Lot No. 133387) for 2 hours in the dark. After another PBST 
wash, the sections were blocked in 5% normal goat serum (Jackson ImmunoResearch) 
for 1 hour. Sections were then incubated in rabbit anti-c-Fos primary antibody (1:5000; 
Millipore; Product No. ABE457; Lot No. 2905394) overnight at 4ºC. Sections were 
washed in PBST, then incubated in goat anti-rabbit secondary antibody (1:500; Jackson 
ImmunoResearch; AlexaFluorⓇ 594 AffiniPure Goat Anti-Rabbit IgG (H+L); Product 
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No. 111-585-045; Lot No. 121581) for 2 hours in the dark. Sections were floated onto 
unsubbed slides and coverslipped with VectashieldⓇ mounting medium with DAPI. 
2.6 CELL IMAGING 
Epiflourescent DRN image stacks were acquired with a Plan-Apochromat 
10x/0.45 NA objective on a Zeiss AxioImager Z2 microscope (Thornwood, NY) 
equipped with a Hamamatsu ORCA-R2 CCD camera (Bridgewater, NJ). An Apotome 
was used for optical sectioning. Presence of Fos, TPH, and double-labeling of TPH and 
Fos was measured with ImageJ software (National Institutes of Health). To calculate Fos 
density, a Fos:area ratio was obtained by dividing the number of labeled Fos nuclei by the 
DRN area (mm2) and used as a measure of global activity. Serotonergic activity was 
measured by quantifying the number of double-labeled TPH+Fos cells, dividing this 
number by the total number of TPH cells, and converting this ratio into a percent. To 
calculate TPH density, a TPH:area ratio was obtained by dividing the number of labeled 
TPH cells by the DRN area (mm2). 
2.7 STATISTICS 
Statistical analyses were performed using GraphPad Prism 7. By-trial freezing 
data were analyzed by three-way analysis of variance (ANOVA) with sex as a between-
subjects variable and cue type and trial as within-subjects variables. Two-way ANOVAs 
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were used to analyze freezing across conditioning sessions, Fos densities, percent 
TPH+Fos, DRN areas, and TPH densities, with sex as a between-subjects variable and 
cue as a within-subjects variable. Significant main effects and interactions (p < 0.05) 
were followed by Sidak or Tukey post-hoc comparisons. Unpaired t-tests were used to 
analyze DRN areas and TPH densities, and F-tests were used to compare variances. 
Linear and nonlinear relationships between fear discrimination and percent TPH+Fos 
were evident in the data. These were assessed with Pearson’s r and a nonlinear regression 
fit of a quadratic function; goodness of fit was quantified with R-squared. 
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3.0  RESULTS 
3.1 FEMALES EXHIBIT MORE RAPID AND ROBUST FEAR 
DISCRIMINATION COMPARED TO MALES          
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Experimental designs of the CS+/CS-, CS+, and no shock conditions are 
described in Figure 1A. No animals were excluded from behavioral analysis. Estrous 
phase was not found to have a significant effect on fear discrimination in females (data 
not shown). For by-trial data in the CS+/CS- condition (Figure 1B), time spent freezing 
was analyzed in 5 trial blocks, each containing 3, 15s cue presentations. Data were 
aggregated and sorted by cue presentation, and freezing was determined by comparing 
freezing levels to the CS+ compared to the CS-. A significant difference in freezing 
between the two cues indicated the presence of fear discrimination. There was a main 
effect of cue (F(1,14) = 28.979, p < 0.001), sex (F(1,14) = 10.137, p =0.007), trial (F(4,56) = 
6.485,  p < 0.001), and a trial by sex interaction (F(4.56) = 3.254, p = 0.018). 
Discrimination was significant in females from trial blocks 2-5 (T2 p = 0.001; T3 p = 
0.002; T4 p = 0.002; T5 p = 0.006), whereas males did not show discrimination until trial 
Figure	 1.	 Differences	 in	 fear	 discrimination.	 A)	 Experimental	 designs	 of	 the	 three	
different	 conditions	 (n	 =	 8/sex).	 B)	 Freezing	 averages	 (±SEM)	 to	 the	 CS+	 and	 CS-	
averaged	 across	 trial	 blocks	 (3,	 15-s	 cue	 presentations)	 for	 animals	 given	 CS+/CS-	
conditioning.	Females	discriminated	between	CS+	and	CS-	by	trial	block	2	of	each	cue	
(*ps	 <	 0.006),	 while	males	 did	 not	make	 this	 discrimination	 until	 trial	 block	 3	 (*ps	 <	
0.04).	Males	displayed	significantly	more	freezing	compared	to	females	to	both	the	CS+	
(#ps	<	0.05)	and	CS-	 (+ps	<	0.05).	*significant	discrimination	within	sex,	 #significant	sex	
difference	on	CS+,	 +significant	sex	difference	on	CS-.	C)	Mean	and	 individual	replicates	
of	freezing	to	CS+	and	CS-	during	conditioning.	Freezing	to	each	cue	was	averaged	over	
15	 presentations	 and	 converted	 to	 a	 percentage	 of	 time	 (±SEM).	 Females	 exhibited	
greater	discrimination	between	CS+	and	CS-	 (***p	<	0.001)	 compared	 to	males	 (*p	<	
0.05).	Males	exhibited	greater	freezing	to	the	CS-	compared	to	females	(**p	<	0.01).	D)	
Mean	 and	 individual	 replicates	 of	 percent	 discrimination	 indices	 ("#$	&'(()*+,"#-	&'(()*+, ×100%)	
(±SEM)	during	conditioning.	An	 index	below	100	signifies	reduced	 freezing	to	the	CS-	
compared	 to	 the	 CS+,	 and	 therefore	 successful	 fear	 discrimination.	 Females	 showed	
more	 robust	discrimination	compared	to	males	 (*p	<	0.05).	E)	Comparison	of	percent	
freezing	(±SEM)	over	conditioning	sessions	between	CS+/CS-	and	CS+	animals.	CS+/CS-	
males	 exhibited	 similar	 levels	 of	 fear	 compared	 to	 CS+	 males,	 but	 CS+/CS-	 females	
exhibited	 less	 total	 fear	 compared	 to	 CS+	 females.	 A	 sex	 difference	 in	 freezing	 in	
CS+/CS-	animals	was	indicative	of	differences	in	fear	discrimination	(*p	<	0.05).	
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blocks 3-5 and were not as robust as females (T3 p = 0.038; T4 p = 0.005; T5 p = 0.020). 
Males displayed higher freezing compared to females to both the CS+ (T3 p = 0.049; T5 
p = 0.026) and CS- (T2 p = 0.001; T3 p = 0.008; T4 p = 0.046). 
Average time spent freezing to either the CS+ or the CS- was calculated by 
converting the average freezing score over the 15s cue presentation to a percentage. 
Females exhibited a more significant difference in freezing between the CS+ and CS- 
(Figure 1C) (p = 0.0006) compared to males (p = 0.0254), with males exhibiting more 
freezing to the CS- compared to females (p = 0.0040). 
For the CS+/CS- condition, a discrimination index was calculated by dividing the 
amount of time freezing to the CS- over the amount of time spent freezing to the CS+ 
over the 45-minute session, then converting this ratio into a percent. A lower index 
indicates more robust fear discrimination, while a higher index indicates the opposite. 
Females had a lower discrimination index as compared to males (Figure 1D) (p = 
0.0245), freezing less to the CS- compared to the CS+ and confirming that females show 
robust fear discrimination. 
         To determine if freezing during CS+/CS- conditioning differed from that in CS+ 
only conditioning, we compared overall time spent freezing (percent of total test time) 
(Figure 1E).  Freezing was similar between groups in males, but females exhibited less 
total fear in the CS+/CS- condition than the CS+ only condition, a reflection of the 
greater fear inhibition to the CS- evident in Figure 1C. There is a significant sex 
difference within the CS+/CS- group, with females spending less total time freezing 
compared to males (p = 0.0355) further supporting previous results of more robust fear 
discrimination. 
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3.2 MALES AND FEMALES HAVE DIFFERENT CORRELATIONS 
BETWEEN CONDITION AND DRN ACTIVITY 
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One female from the “no shock” condition and one female from the CS+/CS- 
condition were excluded from immunohistochemical analysis due to high background 
fluorescence. Immunohistochemistry in DRN revealed successful cytoplasmic labeling of 
TPH and nuclear labeling of Fos (Figure 2A). Two-way ANOVAs of Fos densities 
(Fos/mm2) (Figure 2B) and percent TPH+Fos (Figure 2C) revealed that there were no sex 
differences in either global or serotonergic activity within each condition, respectively; 
however, there were significant changes due to condition. There was a significant 
increase in Fos density with more exposure to the CS+ (Figure 2B, CS+/CS- to no shock, 
p = 0.0051; CS+ to no shock, p = 0.0002), a trend that was reflected in percent TPH+Fos 
(Figure 2C, CS+/CS- to no shock, p = 0.0062; CS+ to no shock, p < 0.0001). 
Interestingly, an F-test revealed that CS+/CS- males had larger variation in 
percent TPH+Fos as compared to CS+/CS- females (Figure 2C) (p = 0.0237). We further 
explored this condition by correlating an animal’s percent TPH+Fos to its discrimination 
index as previously calculated (Figure 2D). A second-order nonlinear quadratic 
Figure	 2.	 Correlation	 between	 condition	 and	 DRN	 activity.	 A)	 Representative	
epifluorescent	stack	images	of	DRN	sections	(approx.	-8.00	mm	Bregma)	from	male	and	
female	 rats	 under	 various	 conditions	 at	 10x	 magnification.	 Serotonergic	 activity	 was	
measured	by	quantifying	double-labeled	 TPH+Fos	 (green+red)	 cells	with	a	DAPI	 (blue)	
counterstain.	Aq:	aqueduct;	DRD:	dorsal	dorsal	raphe;	DRV:	ventral	dorsal	raphe.	Scale	
bar:	100	µm.	B)	Comparison	of	average	Fos	densities	(Fos/mm2)	(±SEM)	between	sexes	
and	across	 conditions.	There	were	no	 sex	differences	 in	overall	 Fos	 immunoreactivity	
within	each	condition,	but	there	were	significant	changes	due	to	condition	(**p	<	0.01,	
***p	 <	0.001).	C)	Comparison	of	 percent	TPH+Fos	 (±SEM)	between	sexes	and	across	
conditions.	There	were	no	sex	differences	 in	overall	TPH+Fos	 immunoreactivity	within	
each	condition,	but	there	were	significant	changes	due	to	condition	(**p	<	0.01,	****p	<	
0.0001).	Notably,	CS+/CS-	males	had	larger	variation	compared	to	CS+/CS-	females	(p	<	
0.05).	 D)	 This	 variation	 was	 furthered	 explored	 by	 correlating	 percent	 TPH+Fos	 to	
discrimination	index.	Males,	but	not	females,	exhibited	a	parabolic	correlation	between	
serotonergic	activity	and	discrimination	index	as	indicated	by	R-squared	values.	
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correlation was determined to be the best fit for males accounting for a majority of data 
variability (R2 = 0.82), as opposed to our original hypothesis of a linear correlation (data 
not shown). A high R-squared value for males, but not females (R2 = 0.24), is suggestive 
of a parabolic correlation between percent TPH+Fos and fear discrimination. 
3.3 DRN MORPHOLOGY CANNOT ACCOUNT FOR DIFFERENCES IN 
SEROTONERGIC ACTIVITY 
 
 
 
We next explored morphological differences in the DRN, regardless of condition, 
to see if this could explain observed sex differences in serotonergic activity. Four males 
were excluded from immunohistochemical analysis as their representative DRN sections 
had significantly larger areas than those of the rest of the sample. An unpaired t-test on 
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Figure	 3.	 DRN	 anatomy.	 A)	 Average	 DRN	 areas	 (mm2)	 (±SEM),	 regardless	 of	
condition.	Males	 and	 females	 had	 similar	 DRN	 areas.	B)	 TPH	 densities	 within	 the	
DRN	 (TPH/mm2)	 (±SEM),	 regardless	 of	 condition.	 Males	 and	 females	 had	 similar	
TPH	 densities.	 C)	 Percent	 TPH+Fos	 (±SEM),	 regardless	 of	 condition.	 Females	 had	
higher	 TPH+Fos	 immunoreactivity	 compared	 to	 males,	 and	 therefore	 higher	
serotonergic	activity	(*p	<	0.05).	Males	had	larger	variation	in	serotonergic	activity	
compared	to	females	(𝜙p	<	0.05).		
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average DRN areas (mm2) (Figure 3A) and TPH densities (TPH/mm2) (Figure 3B) 
revealed that males and females had similar DRN anatomies and comparable TPH 
densities. Regardless of condition, males and females had different serotonergic 
modalities (Figure 3C). Females had higher percent TPH+Fos compared to males (p = 
0.0227), but males had larger variation in serotonergic activity compared to females (p = 
0.0180). These results indicate that DRN morphology alone cannot explain observed sex 
differences in behavior or serotonergic activity. 
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4.0  DISCUSSION 
Based on previous research, serotonergic modulation may account for observed 
sex differences in fear discrimination, a cognitive function relevant to both typical 
behavior and anxiety disorders such as PTSD. We replicated sex differences in a fear 
discrimination paradigm and found via immunohistochemical analysis that females had a 
higher level of serotonergic activity compared to males, whereas males had larger 
variation of serotonergic activity compared to females.  
From an adaptive perspective, females’ rapid and robust discrimination between 
danger and safety may help conserve resources by eliciting appropriate behavioral 
responses only when necessary. Evolutionarily, females would have needed to recognize 
threats and react quickly to protect themselves and their young, as well as take advantage 
of safe opportunities to gather more resources to ensure their own and others’ survival. 
Given enough time, males also learned to discriminate between danger and safety, but 
notably generalized the cues in the beginning of the conditioning session, going on to 
display higher freezing overall and never attaining the same level of discrimination of 
females. Males’ inability to discriminate as well as females need not be seen as a 
disadvantage per se, as this behavior may stem from an evolutionary pressure to be more 
vigilant to address potential threats, such as an intruder to the nest or a predator while 
foraging. 
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While several studies have suggested potential sex differences in serotonergic 
modulation of fear behaviors, these studies have mainly considered the BLA. Mitsushima 
et al. (2006) found that male rats that underwent inescapable restraint stress had higher 
levels of extracellular 5-HT in the BLA as compared to those in similarly-treated female 
rats. However, while Duchesne et al. (2009) reported that females had higher levels of 
amygdaloid 5-HT, they also reported that males had higher levels of 5-HIAA in this 
structure, with a larger 5-HIAA/5-HT ratio indicative of higher 5-HT metabolism due to 
stress. The notion that females exhibit better fear discrimination, yet are more prone to 
depression and anxiety disorders in the human population, might be explained by this 
difference in 5-HT metabolic rate, where the prolonged presence of trace amounts of 5-
HT in the BLA of females facilitates fear discrimination but has detrimental long-term 
effects. 
Even within the raphe nuclei, there are different populations of serotonergic 
neurons that may modulate fear behaviors that our TPH label could not identify. 
Mamounas and Molliver’s (1988) application of the mood-altering neurotoxin p-
chloroamphetamine identified DRN-derived serotonergic “type D” axons that are more 
susceptible to degradation as compared to serotonergic “type M” axons that arise from 
the median raphe nucleus. As “type D” axons are selectively influenced by mood-altering 
compounds, this subpopulation may play a more dominant role in modulating emotional 
state, but may be influenced by its serotonergic neighbors. Lowry (2002) then proposed a 
model for parallel serotonergic circuits that allow integration of the behavioral, 
autonomic, and neuroendocrine responses associated with conditioned fear in the BLA. 
Following their tracing experiments highlighting the DRN-BLA system, Abrams et al. 
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(2005) measured increased serotonergic activity in the DRN after systemic administration 
of anxiogenic drugs using a TPH+Fos double label.  
Acute SSRI treatment (Burghardt et al., 2004) and genetic downregulation of the 
5-HT transporter and the degratory enzyme monoamine oxidase A (Garpenstrand et al., 
2001) led to an increase in 5-HT levels and better fear discrimination, but a genetically 
induced decrease in 5-HT (Dai et al., 2008) was also able to produce this effect. To 
address these results, Homberg (2012) proposed a U-shaped relationship between 5-HT 
levels and the extent of fear conditioning, in which both too high and too low 5-HT levels 
increase associative learning and strengthen CS-US association. In our model, both high 
and low levels of 5-HT correlated with poor fear discrimination in males. To reconcile 
our model with that in Homberg’s review, it is important to remember that our results 
were not influenced by pharmacological or genetic manipulations on the animals—
serotonergic activity in the DRN-BLA system was left in its naturally occurring state. An 
overwhelming amount of 5-HT as a result of further experimental manipulations could 
upregulate the DRN-BLA system such that while the animal may successfully associate 
the CS with the US, it would also exhibit generally higher fear and an inability to 
effectively discriminate. Interestingly, males rats with the greatest CS+/CS- 
discrimination, in fact comparable to female behavior, had TPH+Fos levels that were 
very similar to females. This suggests that, in order to exhibit robust fear discrimination, 
there is an optimal level of 5-HT activity. Previous research demonstrated that 
manipulating serotonergic activity via a receptor antagonist (Foilb and Christianson, 
2015) or a TPH inhibitor (Pettersson et al., 2016) improved fear discrimination in males; 
these mechanisms support our results of variable serotonergic activity and fear 
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discrimination in males and our conclusion that there exists an optimal 5-HT tone for 
males.  
We found that neither a linear nor a nonlinear correlation between serotonergic 
activity and fear discrimination applied to females; instead, their collective activity was 
clustered in one region of the plot. This non-correlation implies that DRN activity does 
not usually play as large a role in the daily activities of females as it does in males, and 
that exposure to stress actually recruits DRN activity in a discrimination task in females. 
Activation of the DRN-BLA pathway in females may lead to a change in BLA plasticity 
mechanisms whereby they are more readily able to identify and distinguish between the 
CS+ and CS-.  
Constant DRN activity in males, and therefore upregulation of the DRN-BLA 
pathway, supports the hypothesis that males evolved to be in a constant vigilant state. 
Assuming lower baseline DRN activity in females also corroborates the idea that the 
DRN is recruited only when the female must identify and react appropriately to either a 
threatening or harmless stimulus, and a narrow range of 5-HT activity in response to 
stress is also in line with females’ assumed greater investment in conserving resources as 
compared to males.  
Exposure to stress as a result of fear conditioning is also associated with the 
release of hormones such as norepinephrine and glucocorticoids, leading to the 
concurrent activation of β-adrenergic and glucocorticoid receptors within the BLA that 
mediates the establishment of long-term fear memory in the nucleus accumbens, 
hippocampus, entorhinal, and insular cortices (McGaugh, 2004). Subsequent ELISA 
testing would indicate whether males and females have different levels of stress 
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hormones as a result of fear discrimination. If males have an upregulated DRN-BLA 
system, then they may have a hormonal tone which is not enough to induce fear memory 
consolidation. On the other hand, the infrequent activation of the DRN-BLA system in 
females would lead to a sharp increase in stress hormone levels which may facilitate fear 
discrimination during the conditioning session. Previous studies (Rainnie, 1999; Wang 
and Aghajanian, 1977; Muller et al., 2007) in which DRN stimulation or exogenous 5-HT 
administration inhibited plasticity mechanisms in BLA did not consider the influence of 
stress hormones on the system.  
These hypotheses cannot be proven until we have a better understanding of neural 
activity in fear behaviors. While the robust and cost-effective immunohistochemical 
labeling of Fos remains the most commonly used method for assessing neural activity, 
there are limitations that prevented us from acquiring as complete a picture of neural 
activation in the DRN as possible. First, while our TPH+Fos double label effectively 
identified the serotonergic neurons that were activated by fear discrimination, we do not 
know the phenotypes of the non-serotonergic neurons that were also activated. These 
neurons may be excitatory or inhibitory and may act on those serotonergic neurons, 
possibly drawing on other brain structures we did not consider in this study and thus 
adding another nuance to serotonergic modulation of fear discrimination. Secondly, Fos 
does not provide much information about the specific firing properties of the neurons that 
express it. Identifying Fos-labeled neurons with different-shaped action potentials and 
different firing patterns would provide more information about neural activity in vivo 
during fear discrimination. Lastly, Fos does not provide much information about the time, 
degree, and duration of activation, only that the neuron had been activated at some point 
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during the conditioning session. As a result, we do not know when or even if these 
neurons take part in the plasticity mechanisms that are implied in CS-US association, 
characteristic of learning and memory, and facilitatory in discriminating between the CS+ 
and CS-.  
Knowledge of inherent sex differences in serotonergic activity and their possible 
implications in the ability to discriminate between what is safe from what is not augments 
our understanding of the higher prevalence of PTSD in women and addresses the urgent 
need to develop better treatments for the disorder. Estrogen has been found to increase 
TPH expression (Hiroi et al., 2006) and maintain serotonergic neurons in the DRN 
(Suzuki et al., 2013). Coupled with the fact that external social pressures may make 
women more susceptible to traumatic events as compared to men, extreme stress in 
women may upregulate the normally “quiet” DRN-BLA system to the point of 
maintaining abnormally high levels of 5-HT and stress hormones which lead to the onset 
of PTSD.  
Despite their continued use, there is no consensus on the efficacy of SSRIs in 
treating anxiety and depressive-related symptoms of PTSD (Mӧller, 2009). Potential sex 
differences in 5-HT metabolism (Duchesne et al., 2009) would consequently lead to sex 
differences in SSRI mechanisms of action. If women with PTSD have higher levels of 5-
HT and a lower rate of 5-HT metabolism due to stress as compared to men, then SSRIs, 
while proven effective for one biological sex, may actually be detrimental to the other. 
Based on our model, a more effective treatment for women with PTSD would be to 
develop pharmaceuticals that decrease serotonergic activity, whose efficacy can then be 
assessed using a fear discrimination paradigm.  
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A future direction for this sex differences study would be to apply the logic and 
technology of “engram” research (Denny et al., 2017; Kim and Cho, 2017) to induce 
activity-dependent labels in serotonergic cells involved in the DRN-BLA pathway to see 
if different neurons are involved in identifying and reacting to the CS+ versus the CS-, 
and, if they are different, to then quantify the amount of serotonin involved in modulating 
either circuit using high-performance liquid chromatography. Electrophysiological 
experiments would also help identify differences in the physiological properties of 
neurons due to sex and/or condition and confirm the extent to which synaptic plasticity—
and therefore learning—is involved in fear discrimination. These methods can also be 
applied to animals subjected to the CS+ and “no shock” conditions to compare 
serotonergic modulation at another level of analysis. 
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